Luxury Highton home beats $3m in landmark sale
A luxurious five-bedroom home near Buckleys Falls at Highton has beaten $3m in a rising area of the suburb.
The voluminous two-storey residence constructed by custom builder Signature Homes Geelong sold for $3.1m recently, after first hitting the market last spring.
Belle Property agent Maree Corda brokered the deal at 50 Rivergum Drive with local business owners who were looking to upgrade in Highton.
Burnett family lists Geelong pub after 45 years
She said the seven-year-old residence was initially offered off-market, with a number of taking private inspections before the listing went live to the public with $3.15m to $3.35m hopes, later sharpened to a $3.1m single price.
'We had a couple of people genuinely interested throwing figures in the low $2m range,' Ms Corda said.
'The buyers are local Highton people who want to stay in Geelong and upgrade.'
The home provides 58 squares of living space, on a 959sq m corner block overlooking the Barwon River.
The home offers palatial living with quality finishes and high ceilings, including Italian and German fixtures and dramatic designer lighting enhances the voluminous space.
A floating staircase connects the levels, while large windows allow natural light to flood the home, with metal louvres fitted to ensure climate control indoors.
The Nobilia kitchen has Dekton benchtops, integrated Liebherr appliances and a butler's pantry and laundry fitted with premium appliances.
The living and dining areas have with double-glazed doors, electric blinds and ducted heating and cooling.
A protected outdoor area adjacent to the pool is equipped with outdoor kitchen prep area, an imported pizza oven, barbecue, and bar fridge.
Ms Corda said the fully automated pool with bubble jets, lighting, and year-round heating, adds a resort-like ambience.
The 4-car garage has a custom 6m roller door, 360-degree camera system, backup battery, and Sons-integrated speakers, with additional storage with internal plumbing.
The property is the second multimillion-dollar sale in Highton in 2025, beaten by a luxury 2529sq m Willowfield Court estate that hit $5.5m in March.
Highton's $875,000 median house price is nearly 5 per cent lower than the same time last year.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Telegraph
34 minutes ago
- Daily Telegraph
LTR Pharma completes ED study milestone
Don't miss out on the headlines from Stockhead. Followed categories will be added to My News. LTR Pharma & co-development partner Aptar Pharma complete extractables study on SPONTAN All identified compounds below ICH safety thresholds for nasal spray-mist erectile dysfunction treatment Leachables study initiated to support FDA regulatory submission under real-world storage conditions Special Report: LTR Pharma has completed a key extractables study for its SPONTAN intranasal spray for erectile dysfunction and kicked off a leachables study as part of a regulatory development program. LTR Pharma (ASX:LTP) said the extractables study, conducted under the supervision of co-development partner Aptar Pharma, evaluated the bottle and pump components of SPONTAN's container closure system. The study confirmed that all detected compounds were below ICH safety thresholds – the internationally recognised standards adopted by the US Food and Drug Administration (FDA) and regulatory authorities worldwide for pharmaceutical impurities. LTR Pharma said the identified compounds would be monitored in the ongoing leachables study. FDA requires extractables and leachables (E&L) studies for all pharmaceutical products to ensure packaging materials do not compromise product safety or efficacy. For nasal spray products, these studies must meet specific regulatory thresholds due to direct tissue exposure. Leachables study now underway The leachables study has started under Aptar Pharma's management, evaluating the potential migration of the compounds from packaging into SPONTAN under real-world storage conditions. LTR Pharma said SPONTAN used industry-standard bottle and pump components as used in multiple FDA-approved nasal spray products. The study will run for at least 24 months to support shelf-life requirements. Consistent with FDA practice for nasal sprays, the company can submit its application once sufficient robust data is available, with study completion continuing post-approval as standard. E&L studies form part of LTR Pharma's comprehensive regulatory strategy following its FDA pre-IND meeting, where the FDA confirmed the proposed development pathway. The company said E&L data were required for the chemistry, manufacturing and controls (CMC) section of its planned new drug application (NDA). With extractables results meeting regulatory requirements, the company progresses to the leachables phase for comprehensive regulatory submission data. Watch: LTR's new appointment Progress on SPONTAN and new US-targeted ROXUS LTR Pharma continues to progress SPONTAN through established regulatory pathways while building commercial foundations through its Australian early access programs. It is also progressing its new ED nasal spray called ROXUS, which offers a fast-track pathway to serve patients through the US personalised healthcare sector. As with SPONTAN, ROXUS is based on the common active ingredient vardenafil. It will be delivered via the 503(a)-compounding pharmacy pathway, which exempts drugs from the usual approval, labelling and manufacturing requirements. "The completion of our extractables study and commencement of the leachables phase keep our regulatory program on schedule,' LTR Pharma executive chairman Lee Rodne said. 'Working with Aptar Pharma provides us with their established expertise in nasal spray device development and FDA submissions. 'These studies are necessary steps in our development pathway, and we look forward to progressing through each regulatory milestone." This article was developed in collaboration with LTR Pharma, a Stockhead advertiser at the time of publishing. This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions. Originally published as LTR Pharma completes study milestone for SPONTAN ED treatment
News.com.au
an hour ago
- News.com.au
‘It is crazy': Melbourne mum builds $100k+ business within two years
A Melbourne mum has doubled her income by bucking the beige trend and embracing colour. Cass Danson, 33, describes herself as a 'visual maximalist' and 'colour junkie', and she's turned it into a business. The young mum amassed a social media following on Instagram by sharing photos of her bright and cheerfully decorated home. She has over 45,000 followers and a highly engaged audience. When people started requesting that she design wallpaper because they loved the murals she had painted in her home, she had an idea. 'The wall decals started from the murals that I was painting around my house. People were asking for wallpaper, but wallpaper is so expensive,' she told 'I thought I'd give it a go with the wall decals; it'll look like wallpaper but way cheaper, and I found a Melbourne printer and gave them a trial.' She launched the business in November 2023, and it couldn't have come at a better time. Ms Danson had been stuck in a career that she was 'so over' and wasn't particularly lucrative. Even when she was working full-time before having kids, she was only making $55,000 a year as a retail manager. The idea of turning what she loved into a business was thrilling but, at first, she was concerned it wouldn't be profitable. Once the business launched, Ms Danson started making money from it pretty much straight away and it was heartening to see that there was an appetite for her designs. 'I was surprised because we're living in the beige era and I didn't know if people were going to vibe with what I was doing,' she said. Customers loved the colourful designs, though, and pretty quickly she was getting messages from people sharing how she had helped them embrace colour. It's been a genuine thrill for Ms Danson, who grew up believing she wasn't 'good at anything' because she was more creatively inclined than academic. She initally started her Instagram account as a way to share her creativity, but she never dreamt it would turn into a business. 'I didn't really set out to do anything but just share what I love,' she said. In the first financial year of her business, Ms Danson cleared $70,000 in profit, but now she's finishing off her second year, which is well over $100,000. She puts the extra cash down to the success of launching her own apparel line, where she sells boldly printed T-shirts and dresses that are both comfortable and fun. 'It is so crazy,' she said. 'Having apparel has taken it to the next level. I don't know why.' Ms Danson said she was nervous to launch it because she 'wasn't sure' if everyone would love it, but the people who do have found her. When she launched her first T-shirt line, the 33-year-old told her husband she'd be happy if she just sold 20 in the first week. Then, on the night the T-shirts went live, she had over 200 people on the website and her phone was blowing up like crazy. 'I was dying! I was like holy sh*t,' she said. Ms Danson said her brother, who helps run the website, actually rang her and said, 'What the f**k is happening?' 'It has taken off,' she said. It's been a massive 12 months and she doesn't often sit back and think about her success, but when she was getting ready for tax time, it really hit home. 'The last few days, I was going through my figures, and I get so anxious about the ATO because it is so different because a business is not paying me,' she said. 'I was working out what I had left, and I was like 'holy s**t'. I said to my husband, 'I can't believe I haven't just sat down and looked at how much the business has profited and how many sales we've done in just one year',' she said. 'I'm excited for this next year because I'm excited to push myself and see what else I can do.'
News.com.au
an hour ago
- News.com.au
Car aiming ‘to replace Tesla'
When Tesla first landed in Australia, many Aussies didn't quite understand what it was but they were captivated by its futuristic design – and they wanted it. At the recent Melbourne International EV Show, News Corp had an exclusive look at a new EV that's provoking that same reaction – XPeng P7+. The P7+ is the latest electric sedan from China and it could be the first to challenge the Tesla Model 3 and BYD Seal, and fill the void left by the discontinued Tesla Model S. Unveiled by TrueEV, XPeng's exclusive Australian importer and distributor, the P7+ hasn't been confirmed for local sale yet. However, TrueEV founder Jason Clarke said the vehicle is under serious evaluation for the Australian market. 'We have to do testing, we know the price point is going to be so much lower, we have to recommend that to XPeng,' he said. Clarke said the absence of the Tesla Model S is 'disappointing' for consumers but the P7+ could be the alternative. 'The P7+ could take the spot as an executive sedan, it fills the void left by the Tesla Model S, which was priced $200,000 plus,' he said. Clarke explained if approved, pricing would likely fall below AUD $100,000. Measuring 5068mm in length with a 3000mm wheelbase, the P7+ is larger than its rivals the BYD Seal and Tesla Model 3. It feels luxurious as if it was made for executives and families. But what sets the P7+ apart is its advanced 'AI-defined' technology which assists with driving and the overall cockpit experience. The car continuously monitors battery usage, drive behaviour, environment, adapting its performance in real time to maximum both range and longevity. The P7+ uses a single rear-mounted motor producing up to 230kW drawing power from a 74.9 LFP battery from EVE Engery Co. Range is officially rated between 580km and 610km (WLTP) which is expected for a family car these days. XPeng claims 10-80 per cent DC fast charging in just 12 minutes on 800V infrastructure, or closer to 20 minutes using current Australian networks. Inside, the cabin features a 15.6-inch infotainment screen, powered by Qualcomm's Snapdragon 8295P chip which controls the X-GPT smart cockpit. There's also an 8-inch rear-seat touchscreen, rear seat heating, ventilation and massage, air purifiers in the glovebox, and dual 50W wireless charges. A panoramic roof with integrated privacy tint adds light and feels seclusive. Boot space is rated at 725L, expanding to 2221L with rear seats folded. There's no spare tyre but a repair kit included. The XPeng P7+ is a bold bet, a sleek and futuristic, tech-loaded executive EV that brings something fresh to Australia. If confirmed for sale locally, this will be one to watch.
